Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 7/20 | 0.50 |
| ▸ | KDM4D | Q6B0I6 | 4/20 | 0.50 |
| ▸ | NAMPT | P43490 | 2/20 | 0.46 |
| ▸ | PDE5A | O76074 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 2/20 | 0.43 |
| ▸ | PDE1A | P54750 | 2/20 | 0.43 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.43 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.43 |
| ▸ | KDM6B | O15054 | 3/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | ATR | Q13535 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18126653 | 0.88 | KDM4C (0.52) | KDM4CKDM4DNAMPTPDE5APDE4A | |
| SCHEMBL535637 | 0.83 | KDM4C (0.58) | KDM4CKDM4DNAMPTKDM6BCYP17A1 | |
| SCHEMBL16703170 | 0.82 | KDM4C (0.60) | KDM4CKDM4DNAMPTKDM6BEGLN3 | |
| SCHEMBL1715214 | 0.79 | ATR (0.56) | KDM4CNAMPTPDE5APDE4APDE1A | |
| SCHEMBL18522430 | 0.77 | NAMPT (0.50) | KDM4CNAMPTCYP17A1ATRRAB9A | |
| Tert-Butylamine SCHEMBL28092552 | 0.76 | HDAC3 (0.52) | KDM4CKDM4DRAB9A | |
| SCHEMBL3717883 | 0.76 | KDM4C (0.50) | KDM4CKDM4DNAMPTPDE5APDE4A | |
| SCHEMBL18126652 | 0.76 | RXFP1 (0.45) | KDM4CNAMPTPDE5APDE4APDE1A | |
| SCHEMBL12955312 | 0.76 | KDM4C (0.55) | KDM4CKDM4DKDM6BEGLN3 | |
| SCHEMBL933049 | 0.75 | KDM4C (0.46) | KDM4CKDM4DNAMPTKDM6BCYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9809573-B2 | Substituted pyridine derivatives useful as GSK-3 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
| US-20160289210-A1 | Substituted Pyridine Derivatives Useful as GSK-3 Inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2016-10-06 | — | — | US | disclosed |
| WO-2015069593-A1 | SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS GSK-3 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289210-A1 | Substituted Pyridine Derivatives Useful as GSK-3 Inhibitors | GSK3B, GSK3A, GRIN3A | KDM4C 3060/4885KDM4D 3133/4885NAMPT 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.